Multiple Myeloma
Cancer of plasma cells. Treatment landscape transformed by proteasome inhibitors, IMiDs, anti-CD38 monoclonal antibodies, BCMA-targeted CAR-T, and bispecific antibodies.
1 Conditions
Cancer of plasma cells. Treatment landscape transformed by proteasome inhibitors, IMiDs, anti-CD38 monoclonal antibodies, BCMA-targeted CAR-T, and bispecific antibodies.
1 Conditions